Main objective: This UQ aims to present an overview of immunological diseases in hemostasis resulting from antibodies directed against coagulation proteins or abnormalities of the complement system. These diseases are in particular all thrombotic microangiopathies, antiphospholipid syndrome, acquired hemophilia or hemostasis during COVID19. This UQ is aimed at students and professionals wishing to acquire the knowledge necessary to manage patients with these pathologies according to the recommendations of expert consensus.
Get to know the clinical characteristics of the different types of MAT in order to make a rapid diagnosis.
Secondary objective: Learn to recognize these often serious diseases which require an emergency diagnosis; know the support circuits.
Publication work are possible and encouraged.
Location: Saint-Antoine Hospital, Paris.
Educational calendar: 36 hours of teaching. Classes will take place in March 2021.
Sending of applications: firstname.lastname@example.org
UQ MAT program and other immunological diseases in Hemostasis